- Home
- VALU vs EBS Comparison
VALU vs EBS Comparison
Compare VALU & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALU
- EBS
- Stock Information
- Founded
- VALU 1931
- EBS 1998
- Country
- VALU United States
- EBS United States
- Employees
- VALU N/A
- EBS N/A
- Industry
- VALU Investment Managers
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- VALU Finance
- EBS Health Care
- Exchange
- VALU Nasdaq
- EBS Nasdaq
- Market Cap
- VALU 379.7M
- EBS 417.8M
- IPO Year
- VALU N/A
- EBS 2006
- Fundamental
- Price
- VALU $39.55
- EBS $7.71
- Analyst Decision
- VALU
- EBS Strong Buy
- Analyst Count
- VALU 0
- EBS 3
- Target Price
- VALU N/A
- EBS $14.33
- AVG Volume (30 Days)
- VALU 6.6K
- EBS 1.0M
- Earning Date
- VALU 03-14-2025
- EBS 03-03-2025
- Dividend Yield
- VALU 3.03%
- EBS N/A
- EPS Growth
- VALU 26.35
- EBS N/A
- EPS
- VALU 2.36
- EBS N/A
- Revenue
- VALU $35,859,000.00
- EBS $1,125,500,000.00
- Revenue This Year
- VALU N/A
- EBS $6.26
- Revenue Next Year
- VALU N/A
- EBS $2.42
- P/E Ratio
- VALU $16.76
- EBS N/A
- Revenue Growth
- VALU N/A
- EBS 2.05
- 52 Week Low
- VALU $32.94
- EBS $1.82
- 52 Week High
- VALU $57.68
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- VALU 47.31
- EBS 28.48
- Support Level
- VALU $32.94
- EBS $7.57
- Resistance Level
- VALU $34.77
- EBS $9.96
- Average True Range (ATR)
- VALU 1.32
- EBS 0.59
- MACD
- VALU 0.76
- EBS -0.35
- Stochastic Oscillator
- VALU 89.69
- EBS 4.07
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under well-known brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and The Most Trusted Name in Investment Research. Its only operating segment being Publishing.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.